ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ORGO Organogenesis Holdings Inc

2.495
0.00 (0.00%)
Pre Market
Last Updated: 13:48:59
Delayed by 15 minutes
Share Name Share Symbol Market Type
Organogenesis Holdings Inc NASDAQ:ORGO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.495 2.45 2.52 25 13:48:59

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

06/09/2023 9:05pm

GlobeNewswire Inc.


Organogenesis (NASDAQ:ORGO)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Organogenesis Charts.

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from September 11th-13th. Management will host a fireside chat to discuss business matters on Monday, September 11th at 8:00 a.m. Eastern Time.

A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

Investor Inquiries:
ICR Westwicke
Mike Piccinino, CFA
OrganoIR@westwicke.com

Press and Media Inquiries:
Organogenesis
Ron O’Brien
communications@organo.com

1 Year Organogenesis Chart

1 Year Organogenesis Chart

1 Month Organogenesis Chart

1 Month Organogenesis Chart

Your Recent History

Delayed Upgrade Clock